Herantis Pharma Plc's directed share issue is oversubscribed multiple times and completed as planned Herantis Pharma Plc's directed share issue is oversubscribed multiple times and completed as planned Herantis Pharma Plc Company release 2 December 2019 at 8:00 pm THE INFORMATION CONTAINED IN...

Herantis Pharma Oyj aloittaa suunnatun osakeannin, suunnittelee rinnakkaislistautumista Nasdaq First North Growth Market Sweden -markkinapaikalle ja laajentaa johtoryhmäänsä Herantis Pharma Oyj aloittaa suunnatun osakeannin, suunnittelee rinnakkaislistautumista Nasdaq First North Growth Market Sweden -markkinapaikalle ja laajentaa johtoryhmäänsä Herantis Pharma Oyj...

Herantis Pharma Plc commences a directed share issue, contemplates secondary listing on Nasdaq First North Growth Market Sweden and expands its management team Herantis Pharma Plc commences a directed share issue, contemplates secondary listing on Nasdaq First North Growth Market Sweden and expands its management team Herantis Pharma Plc Inside information...

Earth Science Tech, Inc. (ETST) Considers Dual Listing of its Common Shares on the Canadian Securities Exchange (CSE) DORAL, Florida, Dec. 11, 2018 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTCQB: ETST) (“ETST" or the “Company"), an innovative biotech company focused on the cannabidiol (CBD), nutraceutical and...

Sorrento Therapeutics Welcomes Jiong Shao as Chief Financial Officer and Reaffirms Intent to Seek Nasdaq/HKSE Dual Listing in 2018 SAN DIEGO, March 19, 2018 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (NASDAQ:SRNE) ("Sorrento") announced today that it appointed Mr Jiong Shao as Executive Vice President and Chief Financial...